Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D06QEN
|
||||
Former ID |
DNC012114
|
||||
Drug Name |
7-Methyl-7H-pyrrolo[3,2-f]quinazoline-1,3-diamine
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [1] | ||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C11H11N5
|
||||
Canonical SMILES |
CN1C=CC2=C1C=CC3=C2C(=NC(=N3)N)N
|
||||
InChI |
1S/C11H11N5/c1-16-5-4-6-8(16)3-2-7-9(6)10(12)15-11(13)14-7/h2-5H,1H3,(H4,12,13,14,15)
|
||||
InChIKey |
WSISEVQVCUARDZ-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Dihydrofolate reductase | Target Info | Inhibitor | [1] | |
PathWhiz Pathway | Folate Metabolism | ||||
Pterine Biosynthesis | |||||
Reactome | E2F mediated regulation of DNA replication | ||||
Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | |||||
Metabolism of folate and pterines | |||||
G1/S-Specific Transcription | |||||
References | |||||
REF 1 | J Med Chem. 1996 Feb 16;39(4):892-903.High-affinity inhibitors of dihydrofolate reductase: antimicrobial and anticancer activities of 7,8-dialkyl-1,3-diaminopyrrolo[3,2-f]quinazolines with small molecular size. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.